Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1998 Aug 1;333(Pt 3):491–495. doi: 10.1042/bj3330491

Characterization of human and rat brain myristoyl-CoA:protein N-myristoyltransferase: evidence for an alternative splice variant of the enzyme.

R A McIlhinney 1, K Young 1, M Egerton 1, R Camble 1, A White 1, M Soloviev 1
PMCID: PMC1219608  PMID: 9677304

Abstract

Using 5'-rapid amplification of cDNA ends, we have identified an extended 5'-end of mRNA coding for human myristoyl-CoA:protein N-myristoyltransferase (NMT). PCR using primers based on this new 5'-sequence and reverse primers within the currently accepted coding sequence of the enzyme resulted in the identification of a novel splice variant of NMT. In vitro translation of these cDNAs resulted in the production of proteins with apparent molecular masses of 63 kDa and 48 kDa. Immunoprecipitation of NMT from human cell lines and immunoblotting of a range of rat tissues has identified proteins with molecular masses corresponding to those derived from these cDNAs, and provided evidence that their relative abundance differs among tissues. Our results provide evidence that this enzyme exists in different forms resulting from alternative splicing of the mRNA.

Full Text

The Full Text of this article is available as a PDF (393.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alaluf S., Mulvihill E. R., McIlhinney R. A. The metabotropic glutamate receptor mGluR4, but not mGluR1 alpha, is palmitoylated when expressed in BHK cells. J Neurochem. 1995 Apr;64(4):1548–1555. doi: 10.1046/j.1471-4159.1995.64041548.x. [DOI] [PubMed] [Google Scholar]
  2. Brockbank S. M., Barth P. T. Cloning, sequencing, and expression of the DNA gyrase genes from Staphylococcus aureus. J Bacteriol. 1993 Jun;175(11):3269–3277. doi: 10.1128/jb.175.11.3269-3277.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bryant M. L., Heuckeroth R. O., Kimata J. T., Ratner L., Gordon J. I. Replication of human immunodeficiency virus 1 and Moloney murine leukemia virus is inhibited by different heteroatom-containing analogs of myristic acid. Proc Natl Acad Sci U S A. 1989 Nov;86(22):8655–8659. doi: 10.1073/pnas.86.22.8655. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bryant M., Ratner L. Myristoylation-dependent replication and assembly of human immunodeficiency virus 1. Proc Natl Acad Sci U S A. 1990 Jan;87(2):523–527. doi: 10.1073/pnas.87.2.523. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Duronio R. J., Reed S. I., Gordon J. I. Mutations of human myristoyl-CoA:protein N-myristoyltransferase cause temperature-sensitive myristic acid auxotrophy in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A. 1992 May 1;89(9):4129–4133. doi: 10.1073/pnas.89.9.4129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Duronio R. J., Rudnick D. A., Johnson R. L., Johnson D. R., Gordon J. I. Myristic acid auxotrophy caused by mutation of S. cerevisiae myristoyl-CoA:protein N-myristoyltransferase. J Cell Biol. 1991 Jun;113(6):1313–1330. doi: 10.1083/jcb.113.6.1313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Giang D. K., Cravatt B. F. A second mammalian N-myristoyltransferase. J Biol Chem. 1998 Mar 20;273(12):6595–6598. doi: 10.1074/jbc.273.12.6595. [DOI] [PubMed] [Google Scholar]
  8. Glover C. J., Hartman K. D., Felsted R. L. Human N-myristoyltransferase amino-terminal domain involved in targeting the enzyme to the ribosomal subcellular fraction. J Biol Chem. 1997 Nov 7;272(45):28680–28689. doi: 10.1074/jbc.272.45.28680. [DOI] [PubMed] [Google Scholar]
  9. Gordon J. I., Duronio R. J., Rudnick D. A., Adams S. P., Gokel G. W. Protein N-myristoylation. J Biol Chem. 1991 May 15;266(14):8647–8650. [PubMed] [Google Scholar]
  10. Göttlinger H. G., Sodroski J. G., Haseltine W. A. Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A. 1989 Aug;86(15):5781–5785. doi: 10.1073/pnas.86.15.5781. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Harper D. R., Gilbert R. L., Blunt C., McIlhinney R. A. Inhibition of varicella-zoster virus replication by an inhibitor of protein myristoylation. J Gen Virol. 1993 Jun;74(Pt 6):1181–1184. doi: 10.1099/0022-1317-74-6-1181. [DOI] [PubMed] [Google Scholar]
  12. Johnson D. R., Duronio R. J., Langner C. A., Rudnick D. A., Gordon J. I. Genetic and biochemical studies of a mutant Saccharomyces cerevisiae myristoyl-CoA:protein N-myristoyltransferase, nmt72pLeu99-->Pro, that produces temperature-sensitive myristic acid auxotrophy. J Biol Chem. 1993 Jan 5;268(1):483–494. [PubMed] [Google Scholar]
  13. Kräusslich H. G., Hölscher C., Reuer Q., Harber J., Wimmer E. Myristoylation of the poliovirus polyprotein is required for proteolytic processing of the capsid and for viral infectivity. J Virol. 1990 May;64(5):2433–2436. doi: 10.1128/jvi.64.5.2433-2436.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Langner C. A., Lodge J. K., Travis S. J., Caldwell J. E., Lu T., Li Q., Bryant M. L., Devadas B., Gokel G. W., Kobayashi G. S. 4-oxatetradecanoic acid is fungicidal for Cryptococcus neoformans and inhibits replication of human immunodeficiency virus I. J Biol Chem. 1992 Aug 25;267(24):17159–17169. [PubMed] [Google Scholar]
  15. Lodge J. K., Jackson-Machelski E., Toffaletti D. L., Perfect J. R., Gordon J. I. Targeted gene replacement demonstrates that myristoyl-CoA: protein N-myristoyltransferase is essential for viability of Cryptococcus neoformans. Proc Natl Acad Sci U S A. 1994 Dec 6;91(25):12008–12012. doi: 10.1073/pnas.91.25.12008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Marc D., Girard M., van der Werf S. A Gly1 to Ala substitution in poliovirus capsid protein VP0 blocks its myristoylation and prevents viral assembly. J Gen Virol. 1991 May;72(Pt 5):1151–1157. doi: 10.1099/0022-1317-72-5-1151. [DOI] [PubMed] [Google Scholar]
  17. McIlhinney R. A., McGlone K. Immunocytochemical characterization and subcellular localization of human myristoyl-CoA: protein N-myristoyltransferase in HeLa cells. Exp Cell Res. 1996 Mar 15;223(2):348–356. doi: 10.1006/excr.1996.0090. [DOI] [PubMed] [Google Scholar]
  18. McIlhinney R. A., Patel P. B., McGlone K. Characterization of a polyhistidine-tagged form of human myristoyl-CoA: protein N-myristoyltransferase produced in Escherichia coli. Eur J Biochem. 1994 May 15;222(1):137–146. doi: 10.1111/j.1432-1033.1994.tb18851.x. [DOI] [PubMed] [Google Scholar]
  19. McIlhinney R. A. The fats of life: the importance and function of protein acylation. Trends Biochem Sci. 1990 Oct;15(10):387–391. doi: 10.1016/0968-0004(90)90237-6. [DOI] [PubMed] [Google Scholar]
  20. Molnár E., Baude A., Richmond S. A., Patel P. B., Somogyi P., McIlhinney R. A. Biochemical and immunocytochemical characterization of antipeptide antibodies to a cloned GluR1 glutamate receptor subunit: cellular and subcellular distribution in the rat forebrain. Neuroscience. 1993 Mar;53(2):307–326. doi: 10.1016/0306-4522(93)90198-o. [DOI] [PubMed] [Google Scholar]
  21. Moscufo N., Simons J., Chow M. Myristoylation is important at multiple stages in poliovirus assembly. J Virol. 1991 May;65(5):2372–2380. doi: 10.1128/jvi.65.5.2372-2380.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Peseckis S. M., Resh M. D. Fatty acyl transfer by human N-myristyl transferase is dependent upon conserved cysteine and histidine residues. J Biol Chem. 1994 Dec 9;269(49):30888–30892. [PubMed] [Google Scholar]
  23. Prange R., Clemen A., Streeck R. E. Myristylation is involved in intracellular retention of hepatitis B virus envelope proteins. J Virol. 1991 Jul;65(7):3919–3923. doi: 10.1128/jvi.65.7.3919-3923.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Rudnick D. A., McWherter C. A., Gokel G. W., Gordon J. I. MyristoylCoA:protein N-myristoyltransferase. Adv Enzymol Relat Areas Mol Biol. 1993;67:375–430. doi: 10.1002/9780470123133.ch5. [DOI] [PubMed] [Google Scholar]
  25. Saermark T., Kleinschmidt A., Wulff A. M., Andreassen H., Magee A., Erfle V. Characterization of N-myristoyl transferase inhibitors and their effect on HIV release. AIDS. 1991 Aug;5(8):951–958. doi: 10.1097/00002030-199108000-00005. [DOI] [PubMed] [Google Scholar]
  26. Tashiro A., Shoji S., Kubota Y. Antimyristoylation of the gag proteins in the human immunodeficiency virus-infected cells with N-myristoyl glycinal diethylacetal resulted in inhibition of virus production. Biochem Biophys Res Commun. 1989 Dec 29;165(3):1145–1154. doi: 10.1016/0006-291x(89)92722-8. [DOI] [PubMed] [Google Scholar]
  27. Weston S. A., Camble R., Colls J., Rosenbrock G., Taylor I., Egerton M., Tucker A. D., Tunnicliffe A., Mistry A., Mancia F. Crystal structure of the anti-fungal target N-myristoyl transferase. Nat Struct Biol. 1998 Mar;5(3):213–221. doi: 10.1038/nsb0398-213. [DOI] [PubMed] [Google Scholar]
  28. Wiegand R. C., Carr C., Minnerly J. C., Pauley A. M., Carron C. P., Langner C. A., Duronio R. J., Gordon J. I. The Candida albicans myristoyl-CoA:protein N-myristoyltransferase gene. Isolation and expression in Saccharomyces cerevisiae and Escherichia coli. J Biol Chem. 1992 Apr 25;267(12):8591–8598. [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES